Impact: Impact - for External Portal › Economic and commerce, Health and welfare - new products, guidelines and services
A computer technology has been invented to accelerate drug discovery. It predicts locations in disease-associated biomolecules where drug molecules could bind, induce shape changes, and thereby bring the activity of the biomolecule under control. A U.S. drug discovery company, Serometrix, has exclusively licensed this technology and incorporated it within their core discovery process. The impact upon them has been: • A step change in their technical approach towards small molecule drug discovery, • Attraction of $227k venture capital funding for the new company direction, • Expansion of workforce (four new personnel by end of 2013), • “Shaving years off” their discovery development programme, • Promising new drug leads, • Planned reduction of early trial compounds “from millions to hundreds”.
Category of impact
Economic and commerce, Health and welfare - new products, guidelines and services